Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

559 Press Releases
DateTitleCompany
21 May 15 America's Most-Preferred Multivitamin Brand Launches New Centrum® MultiGummies Pfizer Inc.,
Published by
Business Wire
19 May 15 Pfizer Invites Public to View and Listen to Webcast of June 2 Conference Call with Analysts to Review Oncology Business and ASCO Data Presentations Pfizer Inc.,
Published by
Business Wire
14 May 15 Pfizer Receives Request For Additional Information From FTC Regarding Proposed Acquisition Of Hospira Pfizer Inc.,
Published by
Business Wire
14 May 15 Marc Tessier-Lavigne Ph.D. to Leave Pfizer Board of Directors Pfizer Inc.,
Published by
Business Wire
14 May 15 Merck and Pfizer to Present Data at ASCO for Avelumab an Investigational Anti-PD-L1 Antibody Pfizer,
Published by
Business Wire
14 May 15 Merck KGaA Darmstadt Germany and Pfizer to Present Data at ASCO for Avelumab an Investigational Anti-PD-L1 Antibody Pfizer Inc. and Merck KGaA, Darmstadt, Germany,
Published by
Business Wire
07 May 15 Summer of TAG Educational Tour to Promote Allergy Awareness in Vancouver and Edmonton Pfizer Canada Inc.,
Published by
PR Newswire
06 May 15 Pfizer Appoints New Leaders for BioTherapeutics Research & Development and Rinat Pfizer Inc.,
Published by
Business Wire
21 Apr 15 Pfizer Receives U.S. FDA Breakthrough Therapy Designation For XALKORI® (crizotinib) For The Treatment Of Patients With ROS1-Positive Non-Small Cell Lung Cancer Pfizer Inc.,
Published by
Business Wire
21 Apr 15 Pfizer Phase 3 Study Of Inotuzumab Ozogamicin Meets Primary Endpoint In Adult Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia Pfizer,
Published by
Business Wire
20 Apr 15 Global Strategic Partners Merck KGaA Darmstadt Germany and Pfizer Initiate Phase III Study with Avelumab* in Patients with Stage IIIb/IV Non-Small Cell Lung Cancer Pfizer Inc.,
Published by
Business Wire
16 Apr 15 Pfizer Invites Public to Listen to Webcast of April 23 Annual Meeting of Shareholders Pfizer Inc.,
Published by
Business Wire
16 Apr 15 Pfizer Launches 2014 Integrated Annual Review Pfizer Inc.,
Published by
Business Wire
15 Apr 15 Pfizer Announces PALOMA-3 Trial For IBRANCE® (Palbociclib) Stopped Early Due To Efficacy Seen In Patients With HR+ HER2- Metastatic Breast Cancer Whose Disease Has Progressed Following Endocrine Therapy Pfizer Inc.,
Published by
Business Wire
09 Apr 15 Pfizer Launches First Annual PCSK9 Competitive Grants Program to Advance Cardiovascular Disease Research Pfizer Inc.,
Published by
Business Wire
06 Apr 15 Kathrin U. Jansen Ph.D. to Lead Pfizer’s Vaccine Research and Development Unit Pfizer Inc.,
Published by
Business Wire
30 Mar 15 Dr. Charles Reay Mackay To Join Pfizer as Chief Scientific Officer Inflammation and Immunology Research Unit Pfizer Inc.,
Published by
Business Wire
24 Mar 15 Pfizer Invites Public To View And Listen To Webcast Of April 28 Conference Call With Analysts Pfizer,
Published by
PharmiWeb.com
24 Mar 15 Pfizer Invites Public To View And Listen To Webcast Of April 28 Conference Call With Analysts Pfizer Inc.,
Published by
Business Wire
24 Mar 15 Pfizer And Lilly Preparing To Resume Phase 3 Chronic Pain Program For Tanezumab Pfizer Inc
23 Mar 15 Pfizer And Lilly Preparing To Resume Phase 3 Chronic Pain Program For Tanezumab Pfizer Inc.,
Published by
Business Wire
20 Mar 15 Pfizer Announces Oral Tofacitinib Meets Primary Endpoints In Pivotal Phase 3 Psoriasis Trials Pfizer Inc.,
Published by
Business Wire
18 Mar 15 Results of Pfizer’s Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA) Published in the New England Journal of Medicine Pfizer Inc.,
Published by
Business Wire
12 Mar 15 Pfizer Reports Top-Line Results From A Phase 4 Study Evaluating LYRICA® Capsules CV As A Treatment For Adolescents With Fibromyalgia Pfizer Inc.,
Published by
Business Wire
03 Mar 15 Pfizer Receives European Approval for New Indication for Prevenar 13 for Prevention of Vaccine-Type Pneumococcal Pneumonia in Adults Pfizer Inc.,
Published by
Business Wire
13 Feb 15 Pfizer Announces FDA Acceptance for Review of a New Drug Application for ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride) Pfizer Inc.,
Published by
Business Wire
10 Feb 15 Pfizer Commences $5 Billion Accelerated Share Repurchase Pfizer Inc.,
Published by
Business Wire
09 Feb 15 Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Investor Conference Pfizer Inc.,
Published by
Business Wire
05 Feb 15 Pfizer Invites Investors Analysts And Media To Join Conference Calls Discussing Pfizer’s Proposed Acquisition of Hospira Pfizer,
Published by
Business Wire
30 Jan 15 NEXIUM CONTROL® NOW AVAILABLE WITHOUT A PRESCRIPTION Pfizer
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.